🔴 Structure Therapeutics is trading 4.07% down as session catalyst remains unclear

Structure Therapeutics is trading 4.07% lower at $24.50, with no clearly linked catalyst identified for the session.

• The broad market is nearly flat, and available evidence does not establish a market-wide cause for the decline.
• Shares had been weakening in recent sessions. No fresh company-specific announcement was identified; the company’s latest listed release was September 8.